Xspray Pharma
XSPRAY | ST
Overview
Corporate Details
- ISIN(s):
- SE0009973563 (+3 more)
- LEI:
- 549300NGRQCNZ3X4L157
- Country:
- Sweden
- Address:
- Scheeles väg 2, 171 65 Solna
- Website:
- https://xspraypharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Xspray Pharma is a pharmaceutical company that utilizes its innovative, patented technology to develop improved versions of marketed drugs, primarily focusing on Protein Kinase Inhibitors (PKIs) for cancer treatment. The company's core strategy involves creating amorphous (non-crystalline) product candidates. This unique formulation allows Xspray Pharma to circumvent the secondary patents of original drugs, which are typically based on crystalline forms. As a result, the company can launch its products upon the expiration of the primary substance patent, securing a favorable market position before traditional generics enter. Xspray Pharma's goal is to provide therapies that offer significant advantages and improve the quality of life for cancer patients.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Xspray Pharma.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-26 13:10 |
Share Issue/Capital Change
Första dag för handel i teckningsrätter och BTAs flyttad till 27 augusti
|
Swedish | 57.3 KB | |
| 2025-08-26 13:10 |
Share Issue/Capital Change
First day of trading in subscription rights and BTAs moved to August 27
|
English | 56.6 KB | |
| 2025-08-25 16:55 |
Share Issue/Capital Change
Xspray publishes disclosure document regarding rights issue
|
English | 58.3 KB | |
| 2025-08-25 16:55 |
Share Issue/Capital Change
Xspray offentliggör informationsdokument avseende företrädesemission
|
Swedish | 58.6 KB | |
| 2025-08-25 16:45 |
Share Issue/Capital Change
Xspray receives additional subscription undertakings of SEK 20 million in the o…
|
English | 60.6 KB | |
| 2025-08-25 16:45 |
Share Issue/Capital Change
Xspray erhåller ytterligare teckningsåtaganden om 20 MSEK i den pågående företr…
|
Swedish | 61.1 KB | |
| 2025-08-15 08:00 |
Interim Report
|
Swedish | 1018.3 KB | |
| 2025-08-15 08:00 |
Interim Report
|
English | 1020.5 KB | |
| 2025-08-15 07:50 |
Share Issue/Capital Change
Xspray beslutar om en företrädesemission om cirka 130 MSEK med en övertilldelni…
|
Swedish | 77.5 KB | |
| 2025-08-15 07:50 |
Share Issue/Capital Change
Xspray resolves on a rights issue of approximately SEK 130 million with an over…
|
English | 77.5 KB | |
| 2025-08-12 08:18 |
Regulatory News Service
Xspray Pharma tecknar licensavtal med Handa Therapeutics – erhåller upp till tv…
|
Swedish | 44.4 KB | |
| 2025-08-12 08:18 |
M&A Activity
Xspray Pharma signs license agreement with Handa Therapeutics – to receive up t…
|
English | 44.2 KB | |
| 2025-07-11 14:10 |
Regulatory News Service
XSpray Pharma achieves significant milestone – demonstrating bioequivalence wit…
|
English | 45.6 KB | |
| 2025-07-11 14:10 |
Regulatory News Service
XSpray Pharma uppnår betydande milstolpe – visar bioekvivalens med absorptionsf…
|
Swedish | 45.8 KB | |
| 2025-06-27 15:55 |
Regulatory News Service
Xspray Pharma Passes FDA Pre-Approval Inspection – Key Regulatory Milestone Ach…
|
English | 44.2 KB |
Automate Your Workflow. Get a real-time feed of all Xspray Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Xspray Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-10 | Anders Ekblom | Other | Buy | 168,000 | 4,998,000.00 SEK |
| 2024-06-04 | Ribbskottet AB Anders Bladh | Other | Buy | 1,958 | 145,655.62 SEK |
| 2024-06-03 | Anders Bladh, Ribbskottet | Other | Buy | 3,042 | 225,077.58 SEK |
| 2024-05-29 | Per Andersson | Other | Buy | 51,749 | 489,545.54 SEK |
| 2024-05-27 | Per Andersson | Other | Sell | 9,950 | 687,545.00 SEK |
| 2024-05-16 | Anders Bladh | Other | Buy | 10,000 | 503,500.00 SEK |
| 2024-05-02 | Maris Hartmanis | Other | Other | 2,385 | 95,400.00 SEK |
| 2024-05-02 | Christine Lind | Other | Other | 666 | 26,640.00 SEK |
| 2024-05-02 | Anders Ekblom | Other | Other | 500 | 20,000.00 SEK |
| 2024-03-05 | Robert Molander | Other | Buy | 5,000 | 20,000.00 USD |
